Form 8-K - Current report:
SEC Accession No. 0001999371-25-004623
Filing Date
2025-04-24
Accepted
2025-04-24 07:06:00
Documents
56
Period of Report
2025-04-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_042425.htm   iXBRL 8-K 28349
2 PRESS RELEASE ex99-01.htm EX-99.01 31612
3 A NOVEL SINGLE-DOSE, ATTENUATED LIVE, MINIMALLY REPLICATIVE MPOX VACCINE ex99-02.htm EX-99.02 48555
7 GRAPHIC ex99-02_img001.jpg GRAPHIC 170891
8 GRAPHIC ex99-02_img002.jpg GRAPHIC 240899
9 GRAPHIC ex99-02_img003.jpg GRAPHIC 75021
10 GRAPHIC ex99-02_img004.jpg GRAPHIC 106619
11 GRAPHIC ex99-02_img005.jpg GRAPHIC 116562
12 GRAPHIC ex99-02_img006.jpg GRAPHIC 110113
13 GRAPHIC ex99-02_img007.jpg GRAPHIC 79339
14 GRAPHIC ex99-02_img008.jpg GRAPHIC 74354
15 GRAPHIC ex99-02_img009.jpg GRAPHIC 221065
16 GRAPHIC ex99-02_img010.jpg GRAPHIC 157970
17 GRAPHIC ex99-02_img011.jpg GRAPHIC 119634
18 GRAPHIC ex99-02_img012.jpg GRAPHIC 93049
19 GRAPHIC ex99-02_img013.jpg GRAPHIC 99805
20 GRAPHIC ex99-02_img014.jpg GRAPHIC 98048
21 GRAPHIC ex99-02_img015.jpg GRAPHIC 143437
22 GRAPHIC ex99-02_img016.jpg GRAPHIC 77767
23 GRAPHIC ex99-02_img017.jpg GRAPHIC 83710
24 GRAPHIC ex99-02_img018.jpg GRAPHIC 150334
25 GRAPHIC ex99-02_img019.jpg GRAPHIC 179943
26 GRAPHIC ex99-02_img020.jpg GRAPHIC 152956
27 GRAPHIC ex99-02_img021.jpg GRAPHIC 151773
28 GRAPHIC ex99-02_img022.jpg GRAPHIC 133987
29 GRAPHIC ex99-02_img023.jpg GRAPHIC 159324
30 GRAPHIC ex99-02_img024.jpg GRAPHIC 154579
31 GRAPHIC ex99-02_img025.jpg GRAPHIC 105632
32 GRAPHIC ex99-02_img026.jpg GRAPHIC 147650
33 GRAPHIC ex99-02_img027.jpg GRAPHIC 77967
34 GRAPHIC ex99-02_img028.jpg GRAPHIC 115445
35 GRAPHIC ex99-02_img029.jpg GRAPHIC 102865
36 GRAPHIC ex99-02_img030.jpg GRAPHIC 96398
37 GRAPHIC ex99-02_img031.jpg GRAPHIC 94247
38 GRAPHIC ex99-02_img032.jpg GRAPHIC 94051
39 GRAPHIC ex99-02_img033.jpg GRAPHIC 112865
40 GRAPHIC ex99-02_img034.jpg GRAPHIC 97190
41 GRAPHIC ex99-02_img035.jpg GRAPHIC 103250
42 GRAPHIC ex99-02_img036.jpg GRAPHIC 83177
43 GRAPHIC ex99-02_img037.jpg GRAPHIC 130086
44 GRAPHIC ex99-02_img038.jpg GRAPHIC 106523
45 GRAPHIC ex99-02_img039.jpg GRAPHIC 135599
46 GRAPHIC ex99-02_img040.jpg GRAPHIC 77813
47 GRAPHIC ex99-02_img041.jpg GRAPHIC 92599
  Complete submission text file 0001999371-25-004623.txt   7087725

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE tnxp-20250423.xsd EX-101.SCH 3023
5 XBRL LABEL FILE tnxp-20250423_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE tnxp-20250423_pre.xml EX-101.PRE 22364
58 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_042425_htm.xml XML 3549
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 25863552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)